Position in MRK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,258,658,860
+$391,940,447 QoQ
Shares Held
27,090,023
-0.5% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.72561285754537.ToString("F0")%
Shared 2.2149002974268424.ToString("F0")%
None 0.05948684502778015.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $32,017,375,581 across 17 Drug Manufacturers - General names. MRK ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,827,564 | $8,119,328,534 | |
| 2 | JNJ |
Johnson & Johnson
|
29,319,669 | $7,166,899,886 | |
| 3 | ABBV |
AbbVie Inc.
|
21,211,382 | $4,613,263,466 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
27,090,023 | $3,258,658,860 | |
| 5 | AMGN |
Amgen Inc
|
6,217,838 | $2,187,746,295 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,820,379 | $1,926,146,218 | |
| 7 | PFE |
Pfizer Inc
|
62,026,552 | $1,741,705,574 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24,758,771 | $1,501,619,457 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,258,658,860 | 27,090,023 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,866,718,413 | 27,234,642 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,344,428,520 | 27,933,141 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,275,487,997 | 28,745,427 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,727,883,948 | 30,390,864 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,121,394,599 | 31,377,107 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,050,830,847 | 26,865,365 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $3,320,350,167 | 26,820,276 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,575,795,648 | 27,099,626 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,106,159,025 | 28,491,644 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,074,048,186 | 29,859,623 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,308,552,197 | 28,672,781 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,243,306,701 | 30,485,071 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,352,230,317 | 30,213,883 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,574,137,218 | 29,890,121 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,730,512,961 | 29,949,687 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,439,806,387 | 29,735,605 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,300,140,294 | 30,012,269 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,330,507,669 | 31,027,928 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,431,201,642 | 31,261,433 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,360,242,042 | 32,086,293 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,565,705,798 | 32,871,160 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,670,578,145 | 33,740,381 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,491,141,575 | 33,760,704 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $2,415,424,500 | 32,900,519 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||